These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34529431)
1. Selective Laser Sintering of a Photosensitive Drug: Impact of Processing and Formulation Parameters on Degradation, Solid State, and Quality of 3D-Printed Dosage Forms. Thakkar R; Davis DA; Williams RO; Maniruzzaman M Mol Pharm; 2021 Oct; 18(10):3894-3908. PubMed ID: 34529431 [TBL] [Abstract][Full Text] [Related]
2. Selective laser sintering additive manufacturing of dosage forms: Effect of powder formulation and process parameters on the physical properties of printed tablets. Tikhomirov E; Åhlén M; Di Gallo N; Strømme M; Kipping T; Quodbach J; Lindh J Int J Pharm; 2023 Mar; 635():122780. PubMed ID: 36849041 [TBL] [Abstract][Full Text] [Related]
3. Formulation Optimization of Selective Laser Sintering 3D-Printed Tablets of Clindamycin Palmitate Hydrochloride by Response Surface Methodology. Mohamed EM; Barakh Ali SF; Rahman Z; Dharani S; Ozkan T; Kuttolamadom MA; Khan MA AAPS PharmSciTech; 2020 Aug; 21(6):232. PubMed ID: 32794080 [TBL] [Abstract][Full Text] [Related]
4. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028 [TBL] [Abstract][Full Text] [Related]
5. Impact of Laser Speed and Drug Particle Size on Selective Laser Sintering 3D Printing of Amorphous Solid Dispersions. Thakkar R; Jara MO; Swinnea S; Pillai AR; Maniruzzaman M Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452109 [TBL] [Abstract][Full Text] [Related]
6. Investigating the Use of Magnetic Nanoparticles As Alternative Sintering Agents in Selective Laser Sintering (SLS) 3D Printing of Oral Tablets. Zhang Y; Thakkar R; Zhang J; Lu A; Duggal I; Pillai A; Wang J; Aghda NH; Maniruzzaman M ACS Biomater Sci Eng; 2023 Jun; 9(6):2924-2936. PubMed ID: 36744796 [TBL] [Abstract][Full Text] [Related]
7. Selective Laser Sintering 3-Dimensional Printing as a Single Step Process to Prepare Amorphous Solid Dispersion Dosage Forms for Improved Solubility and Dissolution Rate. Davis DA; Thakkar R; Su Y; Williams RO; Maniruzzaman M J Pharm Sci; 2021 Apr; 110(4):1432-1443. PubMed ID: 33227241 [TBL] [Abstract][Full Text] [Related]
8. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties. Thakkar R; Zhang Y; Zhang J; Maniruzzaman M Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262 [TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of 3D-Printed Dose-Flexible Printlets of Tenofovir Disoproxil Fumarate. Kayalar C; Rahman Z; Mohamed EM; Dharani S; Khuroo T; Helal N; Kuttolamadom MA; Khan MA AAPS PharmSciTech; 2023 Aug; 24(6):171. PubMed ID: 37566167 [TBL] [Abstract][Full Text] [Related]
10. Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing. Barakh Ali SF; Mohamed EM; Ozkan T; Kuttolamadom MA; Khan MA; Asadi A; Rahman Z Int J Pharm; 2019 Oct; 570():118651. PubMed ID: 31493496 [TBL] [Abstract][Full Text] [Related]
11. Selective laser sintering (SLS) 3D printing of medicines. Fina F; Goyanes A; Gaisford S; Basit AW Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582 [TBL] [Abstract][Full Text] [Related]
12. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data. Seoane-Viaño I; Pérez-Ramos T; Liu J; Januskaite P; Guerra-Baamonde E; González-Ramírez J; Vázquez-Caruncho M; Basit AW; Goyanes A J Control Release; 2024 Jan; 365():348-357. PubMed ID: 37972762 [TBL] [Abstract][Full Text] [Related]
13. Detecting Crystallinity Using Terahertz Spectroscopy in 3D Printed Amorphous Solid Dispersions. Santitewagun S; Thakkar R; Zeitler JA; Maniruzzaman M Mol Pharm; 2022 Jul; 19(7):2380-2389. PubMed ID: 35670498 [TBL] [Abstract][Full Text] [Related]
14. 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering. Tabriz AG; Gonot-Munck Q; Baudoux A; Garg V; Farnish R; Katsamenis OL; Hui HW; Boersen N; Roberts S; Jones J; Douroumis D Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765199 [TBL] [Abstract][Full Text] [Related]
15. Powder bed fusion-laser beam (PBF-LB) three-dimensional (3D) printing: Influence of laser hatching distance on the properties of zolpidem tartrate tablets. Adamov I; Stanojević G; Pavlović SM; Medarević D; Ivković B; Kočović D; Ibrić S Int J Pharm; 2024 May; 657():124161. PubMed ID: 38677394 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of Sustained-Release Dosages Using Powder-Based Three-Dimensional (3D) Printing Technology. Giri BR; Maniruzzaman M AAPS PharmSciTech; 2022 Nov; 24(1):4. PubMed ID: 36447026 [TBL] [Abstract][Full Text] [Related]
17. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes. Patel PJ; Gajera BY; Dave RH Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778 [TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug. Kayalar C; Helal N; Mohamed EM; Dharani S; Khuroo T; Kuttolamadom MA; Rahman Z; Khan MA AAPS PharmSciTech; 2024 Jan; 25(1):20. PubMed ID: 38267637 [TBL] [Abstract][Full Text] [Related]
19. Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. Khan AA; Khuroo T; Mohamed EM; Dharani S; Canberk K; Zhang X; Sangaré LO; Kuttolamadom MA; Rice-Ficht AC; Rahman Z AAPS PharmSciTech; 2024 Sep; 25(7):217. PubMed ID: 39289236 [TBL] [Abstract][Full Text] [Related]
20. 3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs. Kim SJ; Lee JC; Ko JY; Lee SH; Kim NA; Jeong SH Int J Pharm; 2021 Feb; 595():120257. PubMed ID: 33486029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]